Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Clinical Chemistry|August 30, 2021
Circulating Cellular Communication Network Factor 1 Protein as a Sensitive Liquid Biopsy Marker for Early Detection of Breast CancerKai Bartkowiak, Isabel Heidrich, Marcel Kwiatkowski, et al.Journal of Experimental & Clinical Cancer Research : CR|July 12, 2025
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibitionIsabel Heidrich, Charlotte Rautmann, Cedric Ly, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2025
Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinomaGlenn Geidel, Laura Adam, Sabrina Bänsch, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2024
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanomaJulian Kött, Noah Zimmermann, Tim Zell, et al.Frontiers in Cell and Developmental Biology|June 17, 2026
Detection and prognostic role of circulating cancer-associated fibroblasts in the blood of melanoma patientsKim-Lea Reese Ryterski, Hyeong Jung Woo, Svenja Schneegans, et al.International Journal of Cancer|July 12, 2026
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced MelanomaJulian Kött, Glenn Geidel, Carmen M T Roeper, et al.Journal for Immunotherapy of Cancer|May 31, 2023
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitorsJulia-Christina Stadler, Laura Keller, Christian Mess, et al.International Journal of Cancer|May 16, 2026
Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in GermanyGlenn Geidel, Theresa Lowinus, Patrick Metzger, et al.EMBO Molecular Medicine|June 19, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanomaMark Sementsov, Leonie Ott, Julian Kött, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.Pageof 4